MedPath

Retrograde Recanalization of Infrainguinal Arterial Occlusive Disease.

Not Applicable
Conditions
Critical Limb Ischemia
Interventions
Procedure: retrograde access for re-canalization of infra-inguinal arterial occlusive disease
Registration Number
NCT04974905
Lead Sponsor
Sohag University
Brief Summary

The spectrum of lower extremity peripheral arterial disease (PAD) ranges from exhibiting no symptoms to limb threatening gangrene. The number of patients living with it is rising steadily owing to increased life expectancy, obesity, diabetes, and tobacco consumption.

Critical limb ischemia (CLI) is the terminal and the most serious stage of PAD in which blood flow to the lower extremity does not meet metabolic demands of the tissues at rest. The diagnosis is mainly clinical and patients are presented with rest pain, minimal tissue loss or frank gangrene.

Revascularization strategies include endovascular procedures and surgical bypass.Endovascular therapy has evolved as an attractive, minimally invasive method of revascularization especially in the more frequently encountered patients with medical and anatomical contraindications to surgical revascularization.

Antegrade approach is the standard approach in infrainguinal arterial occlusive disease,however, failure occurs in about 20% of infrainguinal attempts.Retrograde approach is used as a backup technique in failed cases.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

patients with;

  1. CLI consistent with Rutherford categories (4-5).
  2. Infrainguinal arterial occlusive disease with a patent distal part of at least one tibial vessel runoff to the foot.
Exclusion Criteria

patients with the following conditions will be excluded:

  1. Non-salvageable limbs.
  2. Life threatening infections requiring major amputation.
  3. Ulcers at the area of intended puncture.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
patients with infrainguinal arterial occlusive disease after failed antegrade approachretrograde access for re-canalization of infra-inguinal arterial occlusive disease-
Primary Outcome Measures
NameTimeMethod
safety of retrograde approach as regard occurrence of procedure specific complicationswithin one year of follow up

safety of retrograde approach after failed antegrade approach for recanalization of infrainguinal arterial occlusive disease, in the light of complications which are classified into major or minor according to the reporting standards of society of vascular surgery.this complications will be looked for and data will be collected

feasibility of retrograde approach as regard successful retrograde puncture and technical success after failed antegrade approach for recanalization of infrainguinal arterial occlusive disease.within one year of follow up

it means that this approach can be used successfuly in clinical practice and this will be assessd by measuring successful retrograde puncture and technical success.

successful retrograde puncture means successful performance of retrograde puncture at any of the retrograde distal puncture sites with intraluminal placement of the retrograde guidewire confirmed by contrast angiography without causing procedure specific complications namely local dissection, rupture, or an arteriovenous fistula at puncture site.

technical success is defined as successful puncture followed by successful crossing of the occlusion and regain of inline flow to the foot with less than 30%residual stenosis after treatment.

Secondary Outcome Measures
NameTimeMethod
clinical success of the procedurewithin one year of follow up

immediate clinical success is defined as regain of distal pulses, revascularization warmness and edema, and/or disappearance of rest pain.

One year limb salvage rate of the procedurewithin one year of follow up

limb salvage is defined as healing of existing wounds with no amputation proximal to metatarsus.

© Copyright 2025. All Rights Reserved by MedPath